{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:26:10Z","timestamp":1790774770128,"version":"4.1.0"},"reference-count":28,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"unspecified","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008645","name":"Terumo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020453","name":"W. L. Gore and Associates","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,2,3]]},"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Type II endoleak (EL) is frequently seen after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA) and is often considered responsible for aneurysm sac enlargement if it persists. In order to reduce type II EL and consequent sac enlargement, pre-emptive embolisation of the inferior mesenteric artery (IMA), which is a main source for persistent type II EL, has been introduced in many vascular centres. At present, there is a lack of robust evidence to support the efficacy of pre-emptive embolisation of IMA on reduction of persistent type II EL with subsequent sac shrinkage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method and analysis<\/jats:title>\n                    <jats:p>This multicentre, randomised controlled trial will recruit 200 patients who have fusiform AAA \u226550\u2009mm\/rapidly enlarging fusiform AAA, with patent IMA, and randomly allocate them either to a pre-emptive IMA embolisation group or non-embolisation control group in a ratio of 1:1. The primary endpoint is the difference of aneurysm sac volume change assessed by CT scans between the pre-emptive IMA embolisation group and the control group at 12 months after EVAR. The secondary endpoints are defined as change of aneurysm sac volume in both groups at 6 and 24 months, freedom from sac enlargement at 12 and 24 months after EVAR, prevalence of type II EL at 1, 6, 12 and 24 months evaluated by contrast-enhanced CT, reintervention rate, aneurysm related mortality, overall survival, perioperative morbidity, volume of contrast media used during EVAR and dosage of radiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The protocol has been reviewed and approved by the ethics committee of Nara Medical University (No. 2113). The findings of this study will be communicated to healthcare professionals, participants and the public through peer-reviewed publications, scientific conferences and the University Hospital Medical Information Network Clinical Trials Registry home page.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>UMIN000035502.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2019-031758","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T04:04:30Z","timestamp":1581912270000},"page":"e031758","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Multicentre randomised controlled trial to evaluate the efficacy of pre-emptive inferior mesenteric artery embolisation during endovascular aortic aneurysm repair on aneurysm sac change: protocol of Clarify IMA study"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1809-4079","authenticated-orcid":false,"given":"Shigeo","family":"Ichihashi","sequence":"first","affiliation":[{"name":"Radiology, Nara Medical University, Kashihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyoshi","family":"Takahara","sequence":"additional","affiliation":[{"name":"Department of Diabetes Care Medicine and Department of Metabolic Medicine, Osaka University, Suita, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Fujimura","sequence":"additional","affiliation":[{"name":"Vascular Surgery, Saiseikai Central Hospital, Minato-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Nagatomi","sequence":"additional","affiliation":[{"name":"Radiology, Nara Medical University, Kashihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Iwakoshi","sequence":"additional","affiliation":[{"name":"Radiology, Nara Medical University, Kashihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bolstad","sequence":"additional","affiliation":[{"name":"Clinical English, Nara Medical University, Kashihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiko","family":"Kichikawa","sequence":"additional","affiliation":[{"name":"Radiology, Nara Medical University, Kashihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,2,16]]},"reference":[{"key":"2025121523530237000_10.2.e031758.1","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/S0140-6736(16)31135-7","article-title":"Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial","volume":"388","author":"Patel","year":"2016","journal-title":"Lancet"},{"key":"2025121523530237000_10.2.e031758.2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1583\/1074-6218(1996)003<0124b:>2.0.CO;2","article-title":"Endoleak--a proposed new terminology to describe incomplete aneurysm exclusion by an endoluminal graft","volume":"3","author":"White","year":"1996","journal-title":"J Endovasc Surg"},{"key":"2025121523530237000_10.2.e031758.3","doi-asserted-by":"publisher","DOI":"10.1067\/mva.2002.118823"},{"key":"2025121523530237000_10.2.e031758.4","doi-asserted-by":"publisher","DOI":"10.1097\/01.RVI.0000085773.71254.86"},{"key":"2025121523530237000_10.2.e031758.5","doi-asserted-by":"publisher","DOI":"10.1583\/12-4188MR.1"},{"key":"2025121523530237000_10.2.e031758.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2012.09.022"},{"key":"2025121523530237000_10.2.e031758.7","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1148\/radiol.14140284","article-title":"CT features of early type II endoleaks after endovascular repair of abdominal aortic aneurysms help predict aneurysm sac enlargement","volume":"274","author":"M\u00fcller-Wille","year":"2015","journal-title":"Radiology"},{"key":"2025121523530237000_10.2.e031758.8","doi-asserted-by":"publisher","DOI":"10.3400\/avd.oa.14-00008"},{"key":"2025121523530237000_10.2.e031758.9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jvs.2015.04.389","article-title":"Type II endoleak with or without intervention after endovascular aortic aneurysm repair does not change aneurysm-related outcomes despite sac growth","volume":"62","author":"Walker","year":"2015","journal-title":"J Vasc Surg"},{"key":"2025121523530237000_10.2.e031758.10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/1358863X17704315","article-title":"Ten-year single-centre experience with type II endoleaks: intervention versus observation","volume":"22","author":"Haq","year":"2017","journal-title":"Vasc Med"},{"key":"2025121523530237000_10.2.e031758.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2011.07.092"},{"key":"2025121523530237000_10.2.e031758.12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.avsg.2016.05.106","article-title":"Preoperative inferior mesenteric artery embolization: a valid method to reduce the rate of type II endoleak after EVAR?","volume":"39","author":"Manunga","year":"2017","journal-title":"Ann Vasc Surg"},{"key":"2025121523530237000_10.2.e031758.13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/SLA.0000000000003299","article-title":"Endovascular aneurysm repair with inferior mesenteric artery embolization for preventing type II endoleak: a prospective randomized controlled trial","volume":"271","author":"Samura","year":"2020","journal-title":"Ann Surg"},{"key":"2025121523530237000_10.2.e031758.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"Spirit 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"2025121523530237000_10.2.e031758.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2013.11.006"},{"key":"2025121523530237000_10.2.e031758.16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jvs.2014.11.003","article-title":"Role of type II endoleak in sac regression after endovascular repair of infrarenal abdominal aortic aneurysms","volume":"61","author":"Kray","year":"2015","journal-title":"J Vasc Surg"},{"key":"2025121523530237000_10.2.e031758.17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s11604-016-0558-y","article-title":"A multi-institutional survey of interventional radiology for type II endoleaks after endovascular aortic repair: questionnaire results from the Japanese Society of endoluminal metallic stents and grafts in Japan","volume":"34","author":"Ogawa","year":"2016","journal-title":"Jpn J Radiol"},{"key":"2025121523530237000_10.2.e031758.18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1253\/circj.CJ-15-0850","article-title":"Characteristics and risk factors for type 2 endoleak in an East Asian population from a Japanese multicenter database","volume":"80","author":"Fujimura","year":"2016","journal-title":"Circ J"},{"key":"2025121523530237000_10.2.e031758.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2007.05.019"},{"key":"2025121523530237000_10.2.e031758.20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/SLA.0000000000002508","article-title":"Outcomes of endovascular repair for abdominal aortic aneurysms: a nationwide survey in Japan","volume":"269","author":"Hoshina","year":"2019","journal-title":"Ann Surg"},{"key":"2025121523530237000_10.2.e031758.21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.avsg.2017.10.016","article-title":"Identification of anatomical risk factors for type II endoleak to guide selective inferior mesenteric artery embolization","volume":"48","author":"Samura","year":"2018","journal-title":"Ann Vasc Surg"},{"key":"2025121523530237000_10.2.e031758.22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170600","article-title":"Prevalence and risk factors of type II endoleaks after endovascular aneurysm repair: a meta-analysis","volume":"12","author":"Guo","year":"2017","journal-title":"PLoS One"},{"key":"2025121523530237000_10.2.e031758.23","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1148\/radiol.13130489","article-title":"Inferior mesenteric arterial type II endoleaks after endovascular repair of abdominal aortic aneurysm: are they predictable?","volume":"270","author":"G\u00fcntner","year":"2014","journal-title":"Radiology"},{"key":"2025121523530237000_10.2.e031758.24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.014902"},{"key":"2025121523530237000_10.2.e031758.25","doi-asserted-by":"publisher","DOI":"10.1007\/s10016-005-7971-5"},{"key":"2025121523530237000_10.2.e031758.26","doi-asserted-by":"publisher","DOI":"10.1583\/06-1882.1"},{"key":"2025121523530237000_10.2.e031758.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-004-0280-6"},{"key":"2025121523530237000_10.2.e031758.28","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2531082093"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-031758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T07:53:09Z","timestamp":1765871589000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-031758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,16]]},"published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1136\/bmjopen-2019-031758"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-031758","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}